Primary results from PATRICIA cohort C (SOLTI-1303), a randomized phase II study evaluating palbociclib with trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer.Eva Ciruelos, Aleix Prat, Rodrigo Sánchez-Bayona et al.|Journal of Clinical Oncology|2024Cited by 8
Palbociclib, Trastuzumab, and Endocrine Therapy in Pretreated HER2-Positive and PAM50 Luminal Advanced Breast Cancer: Randomized Phase II, SOLTI-1303 PATRICIA TrialEva Ciruelos, Aleix Prat, Tomás Pascual et al.|Clinical Cancer Research|2025Cited by 0